Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
CHOP+R
Cancer Type
Regimen Category
Evidence-Informed
Funding Program
ODB - General Benefit
prednisone
New Drug Funding Program
Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma
Drugs Used
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Regimen Monograph
Nov 2023
Patient Info Sheet
Oct 2023
Last Updated: September 10, 2026
